Mukhri Hamdan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mukhri Hamdan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Giribabu Nelli
Department of Physiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia
1 shared publicationGuoqing Zhang
Department of Obstetrics & Gynaecology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia
1 shared publicationHumaira Shah
Department of Obstetrics and Gynaecology, Faculty of Medicine, Universiti Malaya, Lembah Pantai, Kuala Lumpur, Malaysia
1 shared publicationNaguib Salleh
Department of Physiology, Faculty of Medicine, Universiti Malaya, Lembah Pantai, Kuala Lumpur, Malaysia
1 shared publication- Nelli Giribabu
Department of Physiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia
1 shared publication See Ziau Hoe
Department of Physiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia
1 shared publication
Latest Publications
- Open Access
Vitamin D supplementation in infertile men: a systematic review and meta-analysis of effects on semen quality and endocrine function
Objective: To evaluate the effects of oral vitamin D supplementation on semen parameters, reproductive hormones and fertility outcomes in infertile men. Methods: We searched PubMed, Cochrane Library, Web of Science, Scopus and Embase for studies published within the last 10 years. Randomized controlled trials (RCTs) and observational studies evaluating oral vitamin D supplementation in infertile men and reporting semen parameters, reproductive hormones and/or fertility outcomes were included. Risk of bias was assessed using RoB 2.0 (RCTs) and ROBINS-I (observational studies). Results: Eleven studies (eight RCTs and three observational studies; n = 1,168) were included. Vitamin D supplementation was associated with small but statistically significant improvements in semen volume, sperm concentration, progressive motility and serum testosterone. No significant effects were observed on clinical pregnancy or live birth. Reporting of adverse events was limited; no vitamin D-related serious adverse events were reported. Conclusions: Vitamin D supplementation may improve selected semen parameters and testosterone levels in infertile men, particularly progressive sperm motility. However, current evidence does not demonstrate improved clinical fertility outcomes, and higher doses (>4,000 IU/day) do not appear to confer additional benefits. Larger, well-designed trials with standardized fertility endpoints are needed to confirm clinical efficacy.
Open AccessVitamin D supplementation in infertile men: a systematic review and meta-analysis of effects on semen quality and endocrine function
Objective: To evaluate the effects of oral vitamin D supplementation on semen parameters, reproductive hormones and fertility outcomes in infertile men. Methods: We searched PubMed, Cochrane Library, Web of Science, Scopus and Embase for studies published within the last 10 years. Randomized controlled trials (RCTs) and observational studies evaluating oral vitamin D supplementation in infertile men and reporting semen parameters, reproductive hormones and/or fertility outcomes were included. Risk of bias was assessed using RoB 2.0 (RCTs) and ROBINS-I (observational studies). Results: Eleven studies (eight RCTs and three observational studies; n = 1,168) were included. Vitamin D supplementation was associated with small but statistically significant improvements in semen volume, sperm concentration, progressive motility and serum testosterone. No significant effects were observed on clinical pregnancy or live birth. Reporting of adverse events was limited; no vitamin D-related serious adverse events were reported. Conclusions: Vitamin D supplementation may improve selected semen parameters and testosterone levels in infertile men, particularly progressive sperm motility. However, current evidence does not demonstrate improved clinical fertility outcomes, and higher doses (>4,000 IU/day) do not appear to confer additional benefits. Larger, well-designed trials with standardized fertility endpoints are needed to confirm clinical efficacy.
- 14 February 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 387
Molecular mechanisms in endometriosis: linking JAK/STAT pathway, ferroptosis, and microbial dysbiosis
Endometriosis is a chronic gynaecological disorder characterized by ectopic endometrial growth, inflammation, pain, and infertility. Current therapies, largely hormonal and surgical, have limited efficacy and compromise fertility, underscoring the need for alternative approaches that directly address the inflammatory drivers. Recent evidence suggests that gut microbiota dysbiosis and iron overload contribute to the pathophysiology of endometriosis, with excess iron potentially inducing ferroptosis, a regulated form of lipid peroxidation-driven cell death that amplifies inflammation. Concurrently, cytokine-mediated JAK/STAT signalling, particularly IL-6/STAT3, integrates signals from immune cells, ferroptotic processes, and microbial metabolites, positioning it as a central regulatory axis in endometriosis. This review synthesizes mechanistic data linking alterations in the gut microbiota, microbial metabolites, ferroptosis, and JAK/STAT signalling in the inflammatory microenvironment of endometriosis. While direct causal evidence remains limited, converging findings from preclinical and translational studies suggest that the microbiota-ferroptosis-JAK/STAT interaction network forms an interconnected system that contributes to sustained inflammation. Our discussion brings these mechanisms into a shared framework, suggesting that their combined influence may give clearer insight into endometriosis. We propose that exploring these molecular pathways may open new avenues for microbiota- and ferroptosis-informed strategies that target inflammation while preserving fertility.
- 14 February 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 387
Molecular mechanisms in endometriosis: linking JAK/STAT pathway, ferroptosis, and microbial dysbiosis
Endometriosis is a chronic gynaecological disorder characterized by ectopic endometrial growth, inflammation, pain, and infertility. Current therapies, largely hormonal and surgical, have limited efficacy and compromise fertility, underscoring the need for alternative approaches that directly address the inflammatory drivers. Recent evidence suggests that gut microbiota dysbiosis and iron overload contribute to the pathophysiology of endometriosis, with excess iron potentially inducing ferroptosis, a regulated form of lipid peroxidation-driven cell death that amplifies inflammation. Concurrently, cytokine-mediated JAK/STAT signalling, particularly IL-6/STAT3, integrates signals from immune cells, ferroptotic processes, and microbial metabolites, positioning it as a central regulatory axis in endometriosis. This review synthesizes mechanistic data linking alterations in the gut microbiota, microbial metabolites, ferroptosis, and JAK/STAT signalling in the inflammatory microenvironment of endometriosis. While direct causal evidence remains limited, converging findings from preclinical and translational studies suggest that the microbiota-ferroptosis-JAK/STAT interaction network forms an interconnected system that contributes to sustained inflammation. Our discussion brings these mechanisms into a shared framework, suggesting that their combined influence may give clearer insight into endometriosis. We propose that exploring these molecular pathways may open new avenues for microbiota- and ferroptosis-informed strategies that target inflammation while preserving fertility.